The Challenge of Lyme
This rapidly emerging bacterial infection needs new diagnostics.
Read MorePosted by Laurie Bonner | Oct 1, 2020 | Emerging & Zoonotic Diseases |
This rapidly emerging bacterial infection needs new diagnostics.
Read MorePosted by Melanie Hamilton-Basich | Aug 21, 2020 | Cancer, Molecular Diagnostics |
The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from the new hematology-oncology portfolio.
Read MorePosted by | Apr 27, 2020 | Biochemicals & Chemical Reagents, Cancer, Melanoma, Tissue Processing |
The launch focuses on several immunooncology markers that are critical for early-stage cancer drug development and patient treatment.
Read MorePosted by | Apr 10, 2020 | Cancer, Leukemia, Molecular Diagnostics |
The latest update is beneficial to researchers investigating myeloid disorders, and is now enabled with BCR-ABL fusion gene and KMT2A-PTD detection.
Read MorePosted by | Mar 31, 2020 | Computing Systems, Information Technology, Middleware & Software |
Qlucore is expanding its bioinformatics software business into precision medicine and precision diagnostics.
Read More